Journal List > Tuberc Respir Dis > v.66(3) > 1001345

Sim, Lee, Ryu, Chun, and Chang: Prevalence and Risk Factors of Osteoporosis in Patients with Chronic Obstructive Pulmonary Disease

Abstract

Background

Osteoporosis is a significant comorbidity in patients with chronic obstructive pulmonary disease (COPD). This study examined the prevalence and risk factors associated with osteoporosis in patients with COPD.

Methods

The bone mineral densities (BMDs) of the lumbar spine and femoral bone were measured in 53 patients with clinically stable COPD and 41 age- and gender-matched control subjects showing a normal lung function. Osteoporosis was defined as a T-score ≤-2.5. The subjects' clinical characteristics and laboratory data were reviewed, and multiple logistic regression analysis was used to identify the risk factors associated with osteoporosis in COPD patients.

Results

The prevalence of osteoporosis was 47% and 32% in the COPD patients and controls, respectively. In particular, using the femoral neck T-score, the prevalence of osteoporosis in COPD patients was higher than that in the controls (26% vs. 5%; p=0.006). The average T-score of the lumbar spine (p=0.025) and femoral neck of COPD patients were significantly lower than those of the controls (p=0.001). The forced expiratory volume in the 1 second (FEV1) % predicted (p=0.019; odds ratio [OR], 0.955; 95% confidence interval [CI], 0.919-0.993) and age (p=0.024; OR, 1.144; 95% CI, 1.018-1.287) were independently associated with osteoporosis in patients with COPD.

Conclusion

Using the femoral neck T-score, the prevalence of osteoporosis in patients with COPD was higher than the age-and gender-matched controls. A lower FEV1 and older age further increase the risk of osteoporosis in patients with COPD.

Figures and Tables

Table 1
Clinical characteristics in patients with COPD and age- and sex-matched control subjects
trd-66-186-i001

Data are mean±standard deviation (SD) or number (frequency).

COPD: chronic obstructive pulmonary disease; BMI: body mass index; NS: not significant.

Table 2
Lung function in patients with COPD and age- and sex-matched controls
trd-66-186-i002

Data are mean±SD.

COPD: chronic obstructive pulmonary disease; FEV1: forced expiratory volume in 1 second; FVC: forced vital capacity.

Table 3
Laboratory data in patients with COPD and age- and sex-matched controls
trd-66-186-i003

Data are mean±SD.

COPD: chronic obstructive pulmonary disease; CRP: C-reactive protein; ESR: erythrocyte sedimentation rate; NS: not significant.

Table 4
Comparison of bone density parameters and prevalence of osteoporosis in patients with COPD and age- and sex-matched controls
trd-66-186-i004

Data are mean±SD or number (frequency).

COPD: chronic obstructive pulmonary disease; L2-4: the second, third and forth lumbar vertebrae; NS: not significant.

*Osteopenia is defined as a T-score between -1.0 and -2.5, Osteoporosis is defined as a T-score below -2.5.

Table 5
Clinical characteristics of COPD patients according to presence of osteoporosis
trd-66-186-i005

Data are mean±SD or number (frequency).

COPD: chronic obstructive pulmonary disease; BMI: body mass index; NS: not significant.

Table 6
Lung function of COPD patients according to presence of osteoporosis
trd-66-186-i006

Data are mean±SD.

COPD: chronic obstructive pulmonary disease; FEV1: forced expiratory volume in 1 second; FVC: forced vital capacity; NS: not significant.

Table 7
Risk factors of osteoporosis in patients with COPD by multiple logistic regression analyses
trd-66-186-i007

COPD: chronic obstructive pulmonary disease; FEV1: forced expiratory volume in 1 second.

Table 8
Comparison of bone density parameters and prevalence of osteoporosis in COPD patients according to corticosteroid use
trd-66-186-i008

Data are mean±SD or number (frequency).

COPD: chronic obstructive pulmonary disease; L2-4: the second, third and forth lumbar vertebrae; NS: not significant.

*Osteopenia is defined as a T-score between -1.0 and -2.5, Osteoporosis is defined as a T-score below -2.5.

References

1. Chatila WM, Thomashow BM, Minai OA, Criner GJ, Make BJ. Comorbidities in chronic obstructive pulmonary disease. Proc Am Thorac Soc. 2008. 5:549–555.
2. Incalzi RA, Caradonna P, Ranieri P, Basso S, Fuso L, Pagano F, et al. Correlates of osteoporosis in chronic obstructive pulmonary disease. Respir Med. 2000. 94:1079–1084.
3. Iqbal F, Michaelson J, Thaler L, Rubin J, Roman J, Nanes MS. Declining bone mass in men with chronic pulmonary disease: contribution of glucocorticoid treatment, body mass index, and gonadal function. Chest. 1999. 116:1616–1624.
4. Shane E, Silverberg SJ, Donovan D, Papadopoulos A, Staron RB, Addesso V, et al. Osteoporosis in lung transplantation candidates with end-stage pulmonary disease. Am J Med. 1996. 101:262–269.
5. Block JE, Stubbs H. Hip fracture-associated mortality reconsidered. Calcif Tissue Int. 1997. 61:84.
6. Biskobing DM. COPD and osteoporosis. Chest. 2002. 121:609–620.
7. Pauwels RA, Buist AS, Calverley PM, Jenkins CR, Hurd SS. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. Am J Respir Crit Care Med. 2001. 163:1256–1276.
8. American Thoracic Society. Standardization of Spirometry, 1994 Update. Am J Respir Crit Care Med. 1995. 152:1107–1136.
9. Kanis JA, Melton LJ 3rd, Christiansen C, Johnston CC, Khaltaev N. The diagnosis of osteoporosis. J Bone Miner Res. 1994. 9:1137–1141.
10. Jørgensen NR, Schwarz P, Holme I, Henriksen BM, Petersen LJ, Backer V. The prevalence of osteoporosis in patients with chronic obstructive pulmonary disease: a cross sectional study. Respir Med. 2007. 101:177–185.
11. Slemenda CW, Hui SL, Longcope C, Johnston CC Jr. Cigarette smoking, obesity, and bone mass. J Bone Miner Res. 1989. 4:737–741.
12. Daniell HW. Osteoporosis and smoking. JAMA. 1972. 221:509.
13. Bassett CA, Becker RO. Generation of electric potentials by bone in response to mechanical stress. Science. 1962. 137:1063–1064.
14. Cauley JA, Salamone LM, Lucas FL. Marcus R, Feldman D, Kelsey J, editors. Postmenopausal endogenous and exogenous hormones, degree of obesity, thiazide diuretics, and risk of osteoporosis. Osteoporosis. 1996. 1st ed. New York: Academic Press;551–576.
15. Adachi JD. Corticosteroid-induced osteoporosis. Am J Med Sci. 1997. 313:41–49.
16. Lane NE, Lukert B. The science and therapy of glucocorticoid-induced bone loss. Endocrinol Metab Clin North Am. 1998. 27:465–483.
17. Canalis E. Mechanisms of glucocorticoid action in bone: implications to glucocorticoid-induced osteoporosis. J Clin Endocrinol Metab. 1996. 81:3441–3447.
18. Sevenoaks MJ, Stockley RA. Chronic Obstructive Pulmonary Disease, inflammation and co-morbidity--a common inflammatory phenotype? Respir Res. 2006. 7:70.
19. Dalsky GP, Stocke KS, Ehsani AA, Slatopolsky E, Lee WC, Birge SJ Jr. Weight-bearing exercise training and lumbar bone mineral content in postmenopausal women. Ann Intern Med. 1988. 108:824–828.
20. White MK, Martin RB, Yeater RA, Butcher RL, Radin EL. The effects of exercise on the bones of postmenopausal women. Int Orthop. 1984. 7:209–214.
21. Choi JS, An KC, Lee CS, Choi JM, Kim JY, Shin DR. DEXA T-score concordance and discordance between hip and lumbar spine. J Korean Soc Spine Surg. 2003. 10:75–81.
TOOLS
ORCID iDs

Jin Hwa Lee
https://orcid.org/http://orcid.org/0000-0003-0843-9862

Similar articles